evidencegaps
Primary study · included by 1 review

Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer.

Rogers 2017 · Rogers S N, Mepani V, Jackson S, et al. · The British journal of oral & maxillofacial surgery · 2017

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Rogers 2017 · Supplementary Table S3 (included studies); Figs. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · more than 1 year after RIT
Prevalence 0.17 [0.10, 0.28]6 studies · 1005 participantsGRADE not reported

1 including review in total.